Psychosocial and supportive care needs of individuals with advanced myeloma
Abstract
Purpose: The purpose of this qualitative study is to understand, from the patient’s perspective, their experience of living with advanced multiple myeloma, the psychosocial impact, and needs for support in managing and adapting to this illness.
Methods: An interpretive descriptive approach was used. Individual semi-structured telephone interviews were conducted with each participant, which focused on eliciting their descriptions of psychosocial issues and concerns, as well as the supports they use for coping with cancer. Transcripts were analyzed using interpretive description, resulting in the generation of common themes that represented the data.
Results: The sample comprised twelve adults with a diagnosis of advanced multiple myeloma who had undergone at least three lines of treatment or were transfusion dependent. All participants were receiving ambulatory care for their myeloma in Toronto, Ontario, Canada. Four themes were generated: (1) confusion about the diagnosis and treatment options; (2) challenges in finding relevant information; (3) dealing with the chronicity of treatment side effects; (4) social support as critical for coping with the life-threat of multiple myeloma.
Conclusion: Findings suggest that the psychosocial impact of living with advanced multiple myeloma is greatly impacted by one’s ability to understand the complexities of the diagnosis and access supports to cope with its physical and emotional consequences. Clinical interventions specifically tailored to meeting the information and support needs of this population are needed.
Keywords: multiple myeloma, interpretive description, qualitative, psychosocial
Full Text:
PDFReferences
Antes, K., Clark, S., Doherty, C., Forbes, R., Li, M., Nissim, R., Tone, J., & Wilson, L. (2019). Development and implementation of psychosocial assessment and psychosocial care for pre-allogenic BMT patients at Princess Margaret Cancer Centre. Annual Conference of the Canadian Blood and Marrow Transplant Group, Calgary, Alberta, Canada.
Binder, M., Nandakumar, B., Rajkumar, S. V., Kapoor, P., Buadi, F. K., Dingli, D., Lacy, M. Q., Gertz, M. A., Hayman, S. R., Leung, N., Fonder, A., Hobbs, M., Hwa, Y. L., Muchtar, E., Warsame, R., Kourelis, T. V., Gonsalves, W. I., Russell, S., Lin, Y., Siddiqui, M., Kyle, R. A., Dispenzieri, A., & Kumar, S. K. (2022, Mar). Mortality trends in multiple myeloma after the introduction of novel therapies in the United States. Leukemia, 36(3), 801–808. https://doi.org/10.1038/s41375-021-01453-5
Boland, E., Eiser, C., Ezaydi, Y., Greenfield, D. M., Ahmedzai, S. H., & Snowden, J. A. (2013, Nov). Living with advanced but stable multiple myeloma: A study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. Journal of Pain and Symptom Management, 46(5), 671–680. https://doi.org/10.1016/j.jpainsymman.2012.11.003
Cohen, S., & Wills, T. A. (1985). Stress, social support, and the buffering hypothesis. Psychological bulletin, 98(2), 310.
Corbin, J. M., & Strauss, A. (1991). A nursing model for chronic illness management based upon the trajectory framework. Scholarly Inquiry for Nursing Practice, 5(3), 155–174.
Cuffe, C. H., Quirke, M. B., & McCabe, C. (2020). Patients’ experiences of living with multiple myeloma. British Journal of Nursing, 29(2), 103–110. https://doi.org/10.12968/bjon.2020.29.2.103
Dahan, J. F., & Auerbach, C. F. (2006, Dec). A qualitative study of the trauma and posttraumatic growth of multiple myeloma patients treated with peripheral blood stem cell transplant. Palliative & Supportive Care, 4(4), 365–387. https://doi.org/10.1017/s1478951506060470
Hermann, M., Kühne, F., Rohrmoser, A., Preisler, M., Goerling, U., & Letsch, A. (2021). Perspectives of patients with multiple myeloma on accepting their prognosis—A qualitative interview study. Psycho-Oncology, 30(1), 59–66. https://doi.org/https://doi.org/10.1002/pon.5535
Howell, D., Mayo, S., Currie, S., Jones, G., Boyle, M., Hack, T., Green, E., Hoffman, L., Collacutt, V., McLeod, D., & Simpson, J. (2012, Dec). Psychosocial health care needs assessment of adult cancer patients: A consensus-based guideline. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 20(12), 3343–3354. https://doi.org/10.1007/s00520-012-1468-x
Hu, X., Wang, W., Wang, Y., & Liu, K. (2021, Feb). Fear of cancer recurrence in patients with multiple myeloma: Prevalence and predictors based on a family model analysis. Psycho-Oncology, 30(2), 176–184. https://doi.org/10.1002/pon.5546
Jeevanantham, D., Rajendran, V., McGillis, Z., Tremblay, L., Larivière, C., & Knight, A. (2020). Mobilization and exercise intervention for patients with multiple myeloma: Clinical practice guidelines endorsed by the Canadian Physiotherapy Association. Physical Therapy, 101(1). https://doi.org/10.1093/ptj/pzaa180
Kelly, M. D., M., & Meenaghan, T. (2011). Young patients with chronic lymphcytic leaukaemia British Journal of Nursing, 20(17). https://doi.org/https://doi.org/10.12968/bjon.2011.20.Sup10.S30
Kurtin, S. (2017, Aug). Living with multiple nyeloma: A continuum-based approach to cancer survivorship. Seminars in Oncology Nursing, 33(3), 348–361. https://doi.org/10.1016/j.soncn.2017.05.009
Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. SAGE Publications. https://books.google.ca/books?id=2oA9aWlNeooC
Maher, K., & de Vries, K. (2011, Mar). An exploration of the lived experiences of individuals with relapsed multiple myeloma. European Journal of Cancer Care (Engl), 20(2), 267–275. https://doi.org/10.1111/j.1365-2354.2010.01234.x
Molassiotis, A., Wilson, B., Blair, S., Howe, T., & Cavet, J. (2011, Jan). Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology, 20(1), 88–97. https://doi.org/10.1002/pon.1710
Moules, N. J. (2002). Hermeneutic inquiry: Paying heed to history and Hermes an ancestral, substantive, and methodological tale. International Journal of Qualitative Methods, 1(3), 1–21.
Nejati, B., Lin, C. C., Aaronson, N. K., Cheng, A. S. K., Browall, M., Lin, C. Y., Broström, A., & Pakpour, A. H. (2019, Jul). Determinants of satisfactory patient communication and shared decision making in patients with multiple myeloma. Psycho-Oncology, 28(7), 1490–1497. https://doi.org/10.1002/pon.5105
Pai, A. L. H., Swain, A. M., Chen, F. F., Hwang, W.-T., Vega, G., Carlson, O., Ortiz, F. A., Canter, K., Joffe, N., Kolb, E. A., Davies, S. M., Chewning, J. H., Deatrick, J., & Kazak, A. E. (2019). Screening for family psychosocial risk in pediatric hematopoietic stem cell transplantation with the Psychosocial Assessment Tool. Biology of Blood and Marrow Transplantation, 25(7), 1374–1381. https://doi.org/10.1016/j.bbmt.2019.03.012
Potrata, B., Cavet, J., Blair, S., Howe, T., & Molassiotis, A. (2011, Feb). Understanding distress and distressing experiences in patients living with multiple myeloma: An exploratory study. Psycho-Oncology, 20(2), 127–134. https://doi.org/10.1002/pon.1715
Rajkumar, S. V. (2022, Aug). Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. American Journal of Hematology, 97(8), 1086–1107. https://doi.org/10.1002/ajh.26590
Rosati, C., & Tarquini, S. (2015). The introduction of a pre-admission psychosocial assessment process for pediatric allogeneic stem cell transplant patients and families. Biology of Blood and Marrow Transplantation, 21(2), S360–S361. https://doi.org/10.1016/j.bbmt.2014.11.576
Selby, D., Cascella, A., Gardiner, K., Do, R., Moravan, V., Myers, J., & Chow, E. (2010, Feb). A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. Journal of Pain and Symptom Management, 39(2), 241–249. https://doi.org/10.1016/j.jpainsymman.2009.06.010
Shapiro, Y. N., Peppercorn, J. M., Yee, A. J., Branagan, A. R., Raje, N. S., & Donnell, E. K. O. (2021, 2021/10/26). Lifestyle considerations in multiple myeloma. Blood Cancer Journal, 11(10), 172. https://doi.org/10.1038/s41408-021-00560-x
Snowden, J. A., Greenfield, D. M., Bird, J. M., Boland, E., Bowcock, S., Fisher, A., Low, E., Morris, M., Yong, K., Pratt, G., & UK Myeloma Forum (UKMF) and the British Society for Haematology (BSH) (2017). Guidelines for screening and management of late and long-term consequences of myeloma and its treatment. British Journal of Haematology, 176(6), 888–907. https://doi.org/10.1111/bjh.14514
Sonneveld, P., Avet-Loiseau, H., Lonial, S., Usmani, S., Siegel, D., Anderson, K. C., Chng, W. J., Moreau, P., Attal, M., Kyle, R. A., Caers, J., Hillengass, J., San Miguel, J., van de Donk, N. W., Einsele, H., Bladé, J., Durie, B. G., Goldschmidt, H., Mateos, M. V., Palumbo, A., & Orlowski, R. (2016, Jun 16). Treatment of multiple myeloma with high-risk cytogenetics: A consensus of the International Myeloma Working Group. Blood, 127(24), 2955–2962. https://doi.org/10.1182/blood-2016-01-631200
Thoits, P. A. (2011, Jun). Mechanisms linking social ties and support to physical and mental health. Journal of Health and Social Behavior, 52(2), 145–161. https://doi.org/10.1177/0022146510395592
Thorne, S. (2016). Interpretive description: Qualitative research for applied practice. Routledge.
Thorne, S., Kirkham, S. R., & O’Flynn-Magee, K. (2004). The analytic challenge in interpretive description. International Journal of Qualitative Methods, 3(1), 1–11. https://doi.org/https://doi.org/10.1177/160940690400300101
Thorne, S., Kirkham, S. R., & Macdonald-Emes, J. (1997). Interpretive description: A noncategorical qualitative alternative for developing nursing knowledge. Research in Nursing & Health 20(2), 169–177.
van de Donk, N. W. C. J., Pawlyn, C., & Yong, K. L. (2021, 2021/01/30/). Multiple myeloma. The Lancet, 397(10272), 410–427. https://doi.org/https://doi.org/10.1016/S0140-6736(21)00135-5
Vlossak, D., & Fitch, M. I. (2008, Summer). Multiple myeloma: The patient’s perspective. Canadian Oncology Nursing Journal, 18(3), 141–151. https://doi.org/10.5737/1181912x183141145
Zimmermann, C. (2016, Sept). Palliative care for patients with hematological malignancies: Time for a new model. Leukemia Research, 48, 78–79. https://doi.org/10.1016/j.leukres.2016.07.012
Refbacks
- There are currently no refbacks.


